Deutsche Zeitschrift für Onkologie 2010; 42(4): 182-184
DOI: 10.1055/s-0030-1257555
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Apitherapie in der Onkologie

Karsten Münstedt1 , Matthias Kalder2
  • 1Frauenklinik des Universitätsklinikums Gießen und Marburg, Standort Gießen
  • 2Phillips Universität Marburg, Medizinisches Zentrum für Frauenheilkunde, Marburg
Further Information

Publication History

Publication Date:
11 January 2011 (online)


Bienenprodukte und insbesondere Honig finden in den letzten Jahren zunehmend auch in der Onkologie Anwendung. Inhaltsstoffe von Honig und Bienenkittharz haben antiproliferative und immunstimulierende Wirkungen. Honig wird unter anderem erfolgreich bei der lokalen Behandlung von schwer heilenden Wunden und exulzerierenden Tumoren angewendet. Die höchste Evidenz hat derzeit die Vorbeugung und Behandlung der strahlentherapieinduzierten Mukositis bei Kopf-Hals-Tumoren. Aufgrund einer möglichen Problematik in Bezug auf eine Kontamination mit Clostridien sollte medizinischer Honig verwendet werden.


Bee products and especially honey may become important in the field of oncology. Ingredients of honey and propolis (bee glue) have proven antiproliferative and immunostimulant activities. Honey may well be used in cases of poorly healing wounds and ulcerated tumours. Currently the highest evidence for a clinical use is the prophylaxis and treatment of radiation inducted mucositis especially for head and neck cancers. Because of the possibility of infections with clostridia medicinal grade honey is recommended.


  • 01 Bardy J, Slevin N J, Mais K L, Molassiotis A. A systematic review of honey uses and its potential value within oncology care.  J Clin Nurs. 2008;  17 2604-23
  • 02 Biswal B M, Zakaria A, Ahmad N M. Topical application of honey in the management of radiation mucositis: a preliminary study.  Support Care Cancer. 2003;  11 242-8
  • 03 Fukuda M, Kobayashi K, Hirono Y, Miyagawa M, Ishida T, Ejiogu E C, Sawai M, Pinkerton K E, Takeuchi M. Jungle honey enhances immune function and antitumor activity.  Evid Based Complement Alternat Med. 2009;  [Epub ahead of print]
  • 04 Jaganathan S K, Mandal M. Antiproliferative effects of honey and of its polyphenols: a review.  J Biomed Biotechnol. 2009;  2009 830616
  • 05 Keast-Butler J. Honey for necrotic malignant breast ulcers.  Lancet. 1980;  2 (8198) 809
  • 06 Khalil M L. Biological activity of bee propolis in health and disease.  Asian Pac J Cancer Prev. 2006;  7 22-31
  • 07 Majtan J, Majtan V. Is manuka honey the best type of honey for wound care?.  J Hosp Infect. 2010;  74 305-6
  • 08 Moolenaar M, Poorter R L, van der Toorn P P, Lenderink A W, Poortmans P, Egberts A C. The effect of honey compared to conventional treatment on healing of radiotherapy-induced skin toxicity in breast cancer patients.  Acta Oncol. 2006;  45 623-4
  • 09 Motallebnejad M, Akram S, Moghadamnia A, Moulana Z, Omidi S. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial.  J Contemp Dent Pract. 2008;  9 40-7
  • 10 Popolo A, Piccinelli L A, Morello S, Cuesta-Rubio O, Sorrentino R, Rastrelli L, Pinto A. Antiproliferative activity of brown Cuban propolis extract on human breast cancer cells.  Nat Prod Commun. 2009;  4 1711-6
  • 11 Rashad U M, Al-Gezawy S M, El-Gezawy E, Azzaz A N. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.  J Laryngol Otol. 2009;  123 223-8
  • 12 Robson V, Cooper R. Using leptospermum honey to manage wounds impaired by radiotherapy: a case series.  Ostomy Wound Manage. 2009;  55 38-47
  • 13 Robson V, Dodd S, Thomas S. Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial.  J Adv Nurs. 2009;  65 565-75
  • 14 Scarpace S L, Brodzik F A, Mehdi S, Belgam R. Treatment of head and neck cancers: issues for clinical pharmacists.  Pharmacotherapy. 2009;  29 578-92
  • 15 Sutherland S. Several therapies may prevent or reduce the severity of oral mucositis associated with cancer treatment.  Evid Based Dent. 2006;  7 104-5
  • 16 Swellam T, Miyanaga N, Onozawa M, Hattori K, Kawai K, Shimazui T, Akaza H. Antineoplastic activity of honey in an experimental bladder cancer implantation model: in vivo and in vitro studies.  Int J Urol. 2003;  10 213-9
  • 17 Tan H T, Rahman R A, Gan S H, Halim A S, Hassan S A, Sulaiman S A, Kirnpal-Kaur B. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey.  BMC Complement Altern Med. 2009;  9 34
  • 18 Worthington H V, Clarkson J E, Eden O B. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev; 2006 19 (2) CD000978
  • 19 Zidan J, Shetver L, Gershuny A, Abzah A, Tamam S, Stein M, Friedman E. Prevention of chemotherapy-induced neutropenia by special honey intake.  Med Oncol. 2006;  23 549-52


Prof. Dr. med. Karsten Münstedt

Universitätsfrauenklinik Gießen

Klinikstraße 32

35392 Gießen